The book focuses on two concurrent experimental therapies in cancer
treatment known as boron neutron capture therapy (BNCT) and
gadolinium neutron capture therapy (GdNCT) using a variety of
boron- and gadolinium-based compounds. Some of the gadolinium
compounds serve the dual purpose as being MRI contrast agents and
GdNCT agents. The book describes why BNCT & GdNCT were not at
the forefront of the clinical trials during the past seven to eight
decades since the discovery of neutrons by John Chadwick in 1932
and how the latest development in the synthesis of target boron-
and gadolinium-based drugs have turned the area to be the hottest
one and worthy of further investigation with the new clinical
trials in the USA and elsewhere.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!